Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair loss on Wegovy is real, documented in clinical trials, and almost always temporary. The most likely cause is telogen effluvium — a shedding response triggered by rapid weight loss or significant caloric reduction, not by semaglutide itself. In trials, around 3% of people using Wegovy reported hair loss, compared with fewer than 1% in the placebo group. As a listed side effect of Wegovy, it deserves a straight explanation — which is what this page offers. These are prescription-only medicines; clinical assessment determines whether semaglutide is appropriate for you personally.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The honest answer is: probably both, and they are harder to separate than they first appear. In the STEP 1 trial (semaglutide 2.4mg versus placebo over 68 weeks, published in the New England Journal of Medicine) hair loss was reported more often in the semaglutide group than in participants taking a placebo, despite both groups following a similar reduced-calorie diet. That gap tells us semaglutide likely plays some role beyond weight loss alone, possibly through its effect on the body's overall physiology during a period of significant caloric restriction.
At the same time, telogen effluvium is an extremely well-characterised phenomenon that follows any rapid change in nutritional status. Hair follicles cycle through growth and rest phases; a physiological stressor (illness, surgery, childbirth, crash dieting, or fast weight loss) can push a larger-than-usual proportion into the resting (telogen) phase simultaneously. The shed arrives roughly two to four months later, which is why many people notice it mid-treatment rather than at the start. The NHS semaglutide medicines page lists hair loss under uncommon side effects, meaning it affects up to 1 in 10 people who take it.
Framing matters here. Most people experiencing hair loss with Wegovy are losing a greater proportion of their body weight, which is the point of treatment. The hair loss is a secondary consequence of that process, not evidence the medicine is harming you in a lasting way.
For most people, shedding is self-limiting. Once the body adapts to its new caloric baseline and weight stabilises, the proportion of follicles in the resting phase gradually normalises. Regrowth typically becomes visible within six to twelve months of the peak shed, though the timeline varies by individual. This pattern is consistent with telogen effluvium from any cause, the biology is not unique to Wegovy.
There are things that appear to influence severity. Protein adequacy during rapid weight loss is one of the most cited. When caloric intake falls sharply, amino acid availability for non-essential functions (including hair production) can drop. Keeping protein intake sufficient (your prescriber or a dietitian can advise on suitable levels for you) is a practical step that carries no downside. Iron stores are worth checking too; low ferritin is an independent driver of hair thinning in women, and deficiency can deepen a telogen effluvium episode. Ask your GP for a blood test if you are concerned.
A question our prescribers hear regularly: should I stop Wegovy because of hair shedding? In the large majority of cases, no, particularly if treatment is otherwise going well. Stopping prematurely ends the metabolic benefits of semaglutide and does not guarantee faster regrowth, because the follicle cycle runs on its own schedule. That said, the right answer for your situation is one to explore through your prescriber, not a general article. If you are considering the broader Wegovy treatment picture, shedding is one of several side effects worth discussing upfront.
Telogen effluvium produces diffuse thinning across the scalp, you may notice more hair than usual in the shower, on a brush, or on your pillow. What it does not produce is patchy hair loss, loss of eyebrows or eyelashes, scalp soreness, or hair that breaks rather than sheds at the root. Those patterns suggest a different cause that needs a GP's assessment regardless of what medicine you are taking.
Seek prompt medical advice if:
You can report unexpected or severe side effects (including hair loss) directly to the MHRA using the Yellow Card scheme. Reports from patients help the regulator monitor safety signals in real-world use, and you do not need a doctor to submit one. If you have concerns about how hair loss and Wegovy interact for you specifically, it is worth raising them at your next clinical review rather than waiting.
No intervention reverses telogen effluvium faster than the underlying physiology allows. What can be done is avoiding things that worsen it. Aggressive heat styling, tight hairstyles that create traction, and nutrient gaps all add to follicle stress during an already demanding period. Keep the tablet routine or injection-day routine consistent, for those on the once-daily Wegovy pill, that means first thing in the morning before the kettle goes on, with a sip of plain water and nothing else for at least thirty minutes. Consistency matters for the medicine; disrupted routines can affect how well it is absorbed.
For the injection, rotating sites and maintaining the pen in the fridge between uses keeps the medicine stable. Neither of these directly affects hair shedding, but maintaining good treatment adherence ensures you are getting the intended benefit while the follicle cycle normalises.
Some people explore topical minoxidil or nutritional supplements during this period. These are outside the scope of semaglutide prescribing, and any additions should be discussed with a GP or dermatologist. Our clinical team profiles the full side-effect picture, including hair loss that occurs while taking Wegovy and hair loss that continues after Wegovy treatment ends, as part of every consultation, you can read more about how we approach treatment on the about us page or review semaglutide and hair loss in more detail. If you are ready to talk through whether Wegovy suits your circumstances, start your free consultation and a GPhC-registered prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.